Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Treatment
Volume 2017, Article ID 6080648, 11 pages
https://doi.org/10.1155/2017/6080648
Research Article

Evaluating the Measurement Properties of the Self-Assessment of Treatment Version II, Follow-Up Version, in Patients with Painful Diabetic Peripheral Neuropathy

1Astellas Pharma Global Development, Leiden, Netherlands
2Evidera, London, UK
3Evidera, Bethesda, MD, USA

Correspondence should be addressed to Floortje van Nooten; moc.liamtoh@netoonnavejtroolf

Received 7 November 2016; Accepted 6 December 2016; Published 16 January 2017

Academic Editor: Giustino Varrassi

Copyright © 2017 Floortje van Nooten et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. M. Boulton, A. I. Vinik, J. C. Arezzo et al., “Diabetic neuropathies: a statement by the American Diabetes Association,” Diabetes Care, vol. 28, no. 4, pp. 956–962, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Tesfaye, “Advances in the management of diabetic peripheral neuropathy,” Current Opinion in Supportive and Palliative Care, vol. 3, no. 2, pp. 136–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Tesfaye and D. Selvarajah, “The Eurodiab study: what has this taught us about diabetic peripheral neuropathy?” Current Diabetes Reports, vol. 9, no. 6, pp. 432–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Deshpande, R. R. Holden, and I. Gilron, “The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction?” Anesthesia and Analgesia, vol. 102, no. 5, pp. 1473–1479, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. B. O'Connor, “Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy,” PharmacoEconomics, vol. 27, no. 2, pp. 95–112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. J. M. Alleman, K. Y. Westerhout, M. Hensen et al., “Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature,” Diabetes Research and Clinical Practice, vol. 109, no. 2, pp. 215–225, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. National Institute for Health and Care Excellence (NICE), NICE Clinical Guideline 173. Neuropathic Pain—Pharmacological Management. The Pharmacological Management of Neuropathic Pain in Adults in Non-Specialist Settings, 2013, https://www.nice.org.uk/guidance/cg173.
  8. M. P. Jensen, M. J. Chodroff, and R. H. Dworkin, “The impact of neuropathic pain on health-related quality of life: review and implications,” Neurology, vol. 68, no. 15, pp. 1178–1182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. C. Turk, R. H. Dworkin, R. R. Allen et al., “Core outcome domains for chronic pain clinical trials: IMMPACT recommendations,” Pain, vol. 106, no. 3, pp. 337–345, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Carlson, R. Youngblood, J. A. Dalton, W. Blau, and C. Lindley, “Is patient satisfaction a legitimate outcome of pain management?” Journal of Pain and Symptom Management, vol. 25, no. 3, pp. 264–275, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Wiklund, S. Holmstrom, M. Stoker, K. W. Wyrwich, and M. Devine, “Are treatment benefits in neuropathic pain reflected in the Self Assessment of Treatment questionnaire?” Health and Quality of Life Outcomes, vol. 11, article 8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. K. W. Wyrwich, A. K. Kawata, C. Thompson, S. Holmstrom, M. Stoker, and I. Wiklund, “Validation of the Self-Assessment of Treatment questionnaire among patients with postherpetic neuralgia,” Pain Research and Treatment, vol. 2012, Article ID 621619, 15 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. M. Simpson, J. Robinson-Papp, J. Van et al., “Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study,” The Journal of Pain, vol. 18, no. 1, pp. 42–53, 2017. View at Publisher · View at Google Scholar
  14. D. C. Zelman, M. Gore, E. Dukes, K.-S. Tai, and N. Brandenburg, “Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy,” Journal of Pain and Symptom Management, vol. 29, no. 4, pp. 401–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. T. Farrar, J. P. Young Jr., L. LaMoreaux, J. L. Werth, and R. M. Poole, “Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale,” Pain, vol. 94, no. 2, pp. 149–158, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. K. P. Dolan, “10 mistakes to avoid when you apply to a managed-care plan,” Medical Economics, vol. 74, no. 19, pp. 72–83, 1997. View at Google Scholar · View at Scopus
  17. A. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Bouhassira, N. Attal, J. Fermanian et al., “Development and validation of the Neuropathic Pain Symptom Inventory,” Pain, vol. 108, no. 3, pp. 248–257, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. N. K. Leidy, D. A. Revicki, and B. Genesté, “Recommendations for evaluating the validity of quality of life claims for labeling and promotion,” Value in Health, vol. 2, no. 2, pp. 113–127, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. K. W. Wyrwich, N. A. Nienaber, W. M. Tierney, and F. D. Wolinsky, “Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life,” Medical Care, vol. 37, no. 5, pp. 469–478, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. K. W. Wyrwich, W. M. Tierney, and F. D. Wolinsky, “Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life,” Journal of Clinical Epidemiology, vol. 52, no. 9, pp. 861–873, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Shikiar, M. K. Willian, M. M. Okun, C. S. Thompson, and D. A. Revicki, “The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study,” Health and Quality of Life Outcomes, vol. 4, article 71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. R. Norman, J. A. Sloan, and K. W. Wyrwich, “Interpretation of changes in health-related quality of life the remarkable universality of half a standard deviation,” Medical Care, vol. 41, no. 5, pp. 582–592, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Revicki, R. D. Hays, D. Cella, and J. Sloan, “Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes,” Journal of Clinical Epidemiology, vol. 61, no. 2, pp. 102–109, 2008. View at Publisher · View at Google Scholar · View at Scopus